Affiliation: Aarhus University, Denmark

Dr. Zongliang Gao received his PhD from the Department of Microbiology at the University of Amsterdam in 2019. There he worked on the development of gene regulation-based gene therapy against HIV. After the PhD study, he moved to Denmark and is currently a postdoc researcher at Aarhus University, where he focuses on using and developing the CRISPR/Cas9 system for precise gene editing in primary cells such as hematopoietic stem and progenitor cells for therapeutic purposes.